Directory
>
Frank Lee
Frank Lee
Chief Executive Officer | Pacira BioSciences, Inc.
Boston, Massachusetts, United States
Frank Lee
Summary
Frank Lee is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the CEO of Pacira Biosciences, he has demonstrated a strong ability to lead organizations through complex challenges in specialty hospitals and pharmaceutical manufacturing. With a background in chemical engineering and an MBA from Wharton, he combines technical expertise with strategic acumen. Frank has held various leadership roles, including Chairman and Board Member positions in innovative biotech firms. His interests lie in advancing immunological and oncology treatments, showcasing a commitment to improving patient outcomes. Outside of his professional endeavors, Frank is passionate about fostering innovation and leadership development within the healthcare industry.
Frank Lee
Work Experience
Chief Executive Officer at
Pacira BioSciences, Inc.
January 2024 - Present
Board Member at
Bolt Biotherapeutics, Inc.
January 2022 - Present
Chairman of the Board at
Catamaran Bio
March 2022 - March 2024
Executive Chairman at
Therini Bio, Inc.
May 2023 - January 2024
Executive Chairman at
THERINI BIO PTY LTD
May 2023 - January 2024
President and CEO at
Forma Therapeutics
March 2019 - October 2022
SVP, Head, Global Product Strategy, Immunology, Ophthalmology, Infectious Disease at
Genentech Foundation
March 2016 - March 2019
SVP, Head, Global Product Strategy, Immunology, Ophthalmology, Infectious Disease at
Genentech
March 2016 - March 2019
Vice President, Oncology, HER2 Franchise and Oral Oncolytics at
Genentech Foundation
May 2006 - March 2016
Vice President, Oncology, HER2 Franchise and Oral Oncolytics at
Genentech
May 2006 - March 2016
Executive Director, Marketing at
Novartis
November 2003 - April 2006
Director, Worldwide Strategic Marketing at
Johnson & Johnson
November 2002 - November 2003
Frank Lee
Education
Wharton School, Master Of Business Administration (Mba)
January 1994 - January 1996
January 1985 - January 1989
Frequently Asked Questions about Frank Lee
What is Frank Lee email address?
Frank Lee's primary email address is *********@pacira.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Frank Lee work for?
Frank Lee is a Chief Executive Officer at Pacira BioSciences, Inc., a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Frank Lee graduated from?
Frank Lee holds a degree in from Wharton School.
How can I directly contact Frank Lee?
To contact Frank Lee directly, you can use the email address *********@pacira.com. Complete contact information is available upon registration with Muraena.
Who is Frank Lee?
Frank Lee is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the CEO of Pacira Biosciences, he has demonstrated a strong ability to lead organizations through complex challenges in specialty hospitals and pharmaceutical manufacturing. With a background in chemical engineering and an MBA from Wharton, he combines technical expertise with strategic acumen. Frank has held various leadership roles, including Chairman and Board Member positions in innovative biotech firms. His interests lie in advancing immunological and oncology treatments, showcasing a commitment to improving patient outcomes. Outside of his professional endeavors, Frank is passionate about fostering innovation and leadership development within the healthcare industry.
Frank`s contact details
*********@pacira.com
****@catamaranbio.com
Colleagues
Vice President Information Technology
Senior Vice President of Professional Education
Executive Director
Senior Vice President, Communications & Public Affairs
Chief Legal Officer and Chief Compliance Officer
Vice President, UK Operations
Vice President Investor Relations
Executive Director, External Innovation and Bussiness Development
Principal Consultant - Owner
Senior Vice President, Regulatory Affairs